Thus, using modern in silico methods, archived screening data, and state-of-the-art chemical biology techniques, Cyc and its known triazine-containing analogues were herein revisited for their inhibitory activity against human DHFR and as potential cancer therapies. Here, DHFR is linked to cancer.